Skip to main content
Premium Trial:

Request an Annual Quote

Keygene Purchases a Second Sequencer from 454 for SNP Discovery and Detection System

NEW YORK, Jan. 12 (GenomeWeb News) - Keygene has purchased one of 454 Life Sciences' Genome Sequencer 20 for use in its Complexity Reduction of Polymorphic Sequences technology, 

a SNP-discovery single and detection system intended for use in higher eukaryotes with complex genomes, such as plants.

 

In a collaboration announced  earlier this week involving Roche, 454's distributor, Keygene and 454 will use a separate Genome Sequencer 20 with Keygene's AFLP and SNPWave technologies to develop applications in plant genetics.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.